Published in Thorax on September 01, 1985
Why nebulise for more than five minutes? Arch Dis Child (1989) 1.56
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol (2003) 1.27
Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Des Devel Ther (2013) 1.14
Methods to identify drug deposition in the lungs following inhalation. Br J Clin Pharmacol (2001) 1.00
Aerosol antibiotic treatment in cystic fibrosis. Arch Dis Child (1993) 0.98
Inhaled micronised gentamicin powder: a new delivery system. Thorax (1990) 0.94
Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill. Thorax (1990) 0.88
Selecting and using nebuliser equipment. Thorax (1997) 0.86
Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child (1994) 0.86
Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics. Arch Dis Child (1994) 0.84
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol. Drug Des Devel Ther (2014) 0.78
A radiometric study of factors affecting drug output of jet nebulizers. Indian J Pharm Sci (2010) 0.77
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment. Drug Des Devel Ther (2014) 0.77
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
Efficiency of nebulizers for depositing saline in human lung. Am Rev Respir Dis (1973) 1.72
Inhaled antibiotics in cystic fibrosis. Lancet (1983) 1.53
Physical properties of aerosols produced by several jet- and ultrasonic nebulizers. Bull Eur Physiopathol Respir (1984) 1.52
Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis (1977) 1.43
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Production of therapeutic aerosols; principles and techniques. Chest (1981) 0.99
Effect of auxiliary air flow on the output characteristics of compressed-air nebulizers. Ann Allergy (1969) 0.92
Conference on the scientific basis of respiratory therapy. Aerosol therapy. Steroid and antibiotic aerosols. Am Rev Respir Dis (1974) 0.91
Distal penetration in radioaerosol inhalation with an ultrasonic nebulizer. Radiology (1974) 0.88
Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis (1981) 4.16
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax (1984) 3.30
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
Sudden death in asthma. Thorax (1979) 2.72
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg (1995) 2.27
Emergency tracheostomy. Practitioner (1975) 2.18
Acute psychological stress and the propensity to ventricular arrhythmias; evidence for a linking mechanism. Eur Heart J (2000) 2.12
Use of expandable metal stents in the treatment of bronchial obstruction. Thorax (1989) 2.07
Inhalation therapy in asthma. J R Soc Med (1992) 2.01
A study of a brucellosis epidemic. Ir J Med Sci (1970) 1.99
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
Effects of sputum on pulmonary function. Br Med J (1977) 1.94
Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas (1986) 1.87
Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res (1969) 1.77
Psychosocial interventions for caregivers of people with dementia: a systematic review. Aging Ment Health (2001) 1.74
Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev (2004) 1.69
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir (1980) 1.61
Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler. Chest (1993) 1.60
Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J (1994) 1.59
Resistance to two-phase gas-liquid flow in airways. J Appl Physiol (1970) 1.56
Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation (1994) 1.56
What do patients want and do we want to know? A review of patients' requests of psychiatric services. Acta Psychiatr Scand (1999) 1.53
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
A comparison of biopsy results using rigid and fibreoptic bronchoscopes. Br J Dis Chest (1980) 1.47
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol (1996) 1.44
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J (1989) 1.43
Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. Thorax (1986) 1.42
Histological demonstration of copper and copper-associated protein in chronic liver diseases. J Clin Pathol (1978) 1.42
Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest (1989) 1.41
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Selective bronchography using the fibreoptic bronchoscope. Br J Dis Chest (1982) 1.36
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med (1980) 1.36
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis (1978) 1.33
Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl (1983) 1.33
Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer (2009) 1.32
Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth (1996) 1.32
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis (1983) 1.30
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer (2004) 1.29
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur J Nucl Med (1992) 1.20
Cerebral consequences of cardiopulmonary bypass. Lancet (1986) 1.20
Airways penetration of inhaled radioaerosol: an index to small airways function? Eur J Respir Dis (1981) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis (1974) 1.17
The effect of expiratory flow rate on regional lung emptying. Clin Sci (1969) 1.15
Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax (1981) 1.14
A technique for monitoring the inhalation of cigarette smoke in man, using krypton-81m. Int J Appl Radiat Isot (1980) 1.13
An analysis of the first 300 fibreoptic bronchoscopies at the Brompton Hospital. Br J Dis Chest (1979) 1.11
A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum (1999) 1.11
Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax (1979) 1.10
Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 1.09
Pulmonary function in inflammatory bowel disease. Digestion (1978) 1.08
Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy. Eur J Respir Dis (1985) 1.08
Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax (1983) 1.08
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. Br J Cancer (2007) 1.08
What do patients expect of psychiatric services? A systematic and critical review of empirical studies. Soc Sci Med (2001) 1.06
Wastage of drug from nebulisers: a review. J R Soc Med (1987) 1.06
The concerted regulation of cPLA2, COX2, and lipocortin 1 expression by IL-1beta in A549 cells. Biochem Biophys Res Commun (1996) 1.05
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
Ocular dominance, reading, and spelling ability in schoolchildren. Br J Ophthalmol (1985) 1.04
Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers. Clin Pharmacokinet (1999) 1.04
Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (1988) 1.03
The retention of lung secretions during the night in normal subjects. Clin Sci Mol Med Suppl (1978) 1.03
Cerebrospinal fluid-intracranial volume ratio measurements in patients with HIV infection: CLASS image analysis technique. Radiology (1994) 1.02
Techniques for measuring lung mucociliary clearance. Eur J Respir Dis Suppl (1980) 1.02